Days
-
Hours
-
Minutes
-
Seconds
-
Thursday, August 13, 2026
8:30 PM - 9:30 PM EDT
ANDEMBRY® (garadacimab-gxii) Patient Education Webinar
Day, Month Date, Year0:00 PM - 0:00 PM CST

ANDEMBRY® (garadacimab-gxii) Patient Education Webinar




Live educational webinar to learn about the first and only approved prophylaxis treatment for HAE patients proven to work differently from other options by inhibiting Factor XIIa at the top of the HAE cascade.

This program offers you and your loved ones the opportunity to:

  • Learn about a once-monthly prophylactic HAE treatment option delivered in ≤15 seconds via an autoinjector
  • Discover how you or your loved one may experience sustained protection from HAE attacks, starting at week 1 
  • Hear from a Patient Advocate* who will share their experience living with HAE and taking ANDEMBRY
  • Ask questions during the live Q&A session

Key reasons to attend

  • Gain insight into the need for innovative treatment options for MDD
  • Discover the unique mechanism of action of Rejoyn
  • Explore the clinical evidence supporting the efficacy and safety of Rejoyn
  • Learn how to prescribe Rejoyn and augment your patient’s MDD treatment without additional side effects
  • Participate in a live Q&A session and get expert answers to your questions.

Meet the presenter(s)



*Advocates are not healthcare providers or medical experts and are compensated for their participation. For medical questions, you should contact your physician.

Register Today

Test your connection

IMPORTANT SAFETY INFORMATION

What is ANDEMBRY?

ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.

It is not known if ANDEMBRY is safe and effective in children under 12 years of age.

What should I tell my healthcare provider before using ANDEMBRY?

Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.

Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.

How should I use ANDEMBRY? 

Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.

ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.

What are the possible side effects of ANDEMBRY? 

The most common side effects of ANDEMBRY include:

  • Redness, itchiness, and bruising (injection-site reactions)
  • Stomach (abdominal) pain
  • Runny or stuffy nose, sneezing, watery eyes (nasopharyngitis)

Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.